Logotype for National Atomic Company Kazatomprom JSC

National Atomic Company Kazatomprom JSC (KZAP) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for National Atomic Company Kazatomprom JSC

Q2 2024 earnings summary

23 Jan, 2026

Executive summary

  • CFO Sultan Temirbayev resigned, with Marat Tulebayev, who has extensive internal and external experience, expected to assume the role pending corporate approval.

  • Revenue rose 13% year-over-year to KZT 701.1 billion, with net profit up 27% to KZT 283.2 billion, driven by higher uranium prices and increased demand for enriched uranium products.

  • Emphasized the growing importance of nuclear energy and the company's role in the global energy transition.

  • Strategic moves included new production and exploration licenses and addressing uranium supply-demand imbalances.

  • Reaffirmed commitment to operational sustainability, transparency, and fulfilling sales commitments despite production adjustments.

Financial highlights

  • Group consolidated revenue reached KZT 701.1 billion (+13% YoY); net profit rose 27% to KZT 283.2 billion; adjusted EBITDA increased 14% to KZT 377.0 billion.

  • Operating profit declined 10% to KZT 226.7 billion due to a 38% increase in cost of sales, mainly from higher uranium purchase costs.

  • C1 cash costs and all-in sustaining cash costs increased by 38% and 45%, respectively, due to higher MET tax and sulfuric acid costs.

  • Capital expenditures rose 64% YoY, driven by well field development and higher material costs.

  • 2023 dividend payment totaled KZT 315 billion, over 50% higher than the previous year, with industry-leading yield.

Outlook and guidance

  • 2025 production guidance revised to 25,000–26,500 tU, about 12% growth over 2024, due to sulfuric acid supply uncertainty and JV Budenovskoye delays.

  • 2024 production guidance increased to 22,500–23,500 tU (100% basis), with attributable production at 11,600–12,600 tU.

  • 2024 CapEx estimates adjusted upward to KZT 260–280 billion; excess production to replenish inventories.

  • No changes to 2024 sales guidance; inventory levels expected to be sufficient by year-end.

  • MET rate for uranium to rise to 9% in 2025, with a differentiated approach from 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more